| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Galectin Therapeutics Inc (GALT) has 14 insiders with recent SEC Form 4 filings, including 2 buys and 11 sells. GALT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 10.33M | $21.70M | - | |
| 10% | 5.61M | $11.79M | - | |
| CFO | 100.0K | $210.0K | - | |
| CEO | 100.0K | $210.0K | - | |
| Other | 100.0K | $210.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 15, 2021 | 10x Fund, L.P.85 | 10% Owner | Sell | 10,000 | $3.37 | $33,700.00 | -0.2% | -39.8% | -51.9% | |
| Oct 4, 2021 | 10x Fund, L.P.85 | 10% Owner | Sell | 10,000 | $3.62 | $36,200.00 | -0.2% | -37.4% | -55.0% | |
| Sep 23, 2021 | Freeman Kevin D56 | Director | Buy | 3,000 | $3.88 | $11,631.00 | +10.0% | -42.2% | -58.8% | |
| Sep 1, 2021 | 10x Fund, L.P.85 | 10% Owner | Sell | 10,000 | $3.91 | $39,100.00 | -0.2% | -32.6% | -53.1% | |
| Aug 2, 2021 | 10x Fund, L.P.85 | 10% Owner | Sell | 10,000 | $3.25 | $32,500.00 | -0.2% | +3.2% | -29.7% | |
| Jul 9, 2021 | 10x Fund, L.P.85 | - | Sell | 10,000 | $3.54 | $35,400.00 | -0.2% | +2.6% | -50.1% | |
| Jun 1, 2021 | 10x Fund, L.P.85 | - | Sell | 10,000 | $3.91 | $39,100.00 | -0.2% | -4.2% | -59.7% | |
| May 3, 2021 | 10x Fund, L.P.85 | 10% Owner | Sell | 27,500 | $3.97 | $109,275.00 | -0.1% | -16.1% | -58.2% | |
| Apr 5, 2021 | Freeman Kevin D56 | Director | Buy | 5,000 | $2.04 | $10,200.00 | +20.0% | +40.1% | -21.7% | |
| Apr 1, 2021 | 10x Fund, L.P.85 | 10% Owner | Sell | 10,000 | $2.16 | $21,600.00 | -0.2% | +45.5% | -28.2% |